Brain
Glioblastoma
Anthracyclines
Blood Brain Barrier
Technology
Berubicin
Pipeline
Team
Management
Board
About Us
Contact
Investors
Sign Up
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Analyst Coverage
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
1-A
1-A-W
1-A/A
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
C
C-AR
C-TR
C-U
CERT
CORRESP
DEF 14A
DOS
DRS
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
Date
Form
Description
PDF
XBRL
Pages
06/15/18
C-U
Progress Update
4
06/15/18
1-A
Regulation A Offering Statement
Documents
EX1A-3 HLDRS RTS
EX1A-3 HLDRS RTS
EX1A-3 HLDRS RTS
EX1A-6 MAT CTRCT
EX1A-6 MAT CTRCT
EX1A-6 MAT CTRCT
EX1A-6 MAT CTRCT
EX1A-6 MAT CTRCT
EX1A-11 CONSENT
150
04/17/18
DOS
Documents
EX1A-2A CHARTER
EX1A-2B BYLAWS
85
03/13/18
C
103
Previous
1…
18
19
20
21
22
23
24
25
26
27
Email Alerts
Tear Sheet
Contacts
RSS News Feed
Brain
Glioblastoma
Anthracyclines
Blood Brain Barrier
Technology
Berubicin
Pipeline
Team
Management
Board
About Us
Contact
Investors
Sign Up
